Correlation Between Sofwave Medical and Clal Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sofwave Medical and Clal Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sofwave Medical and Clal Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sofwave Medical and Clal Biotechnology Industries, you can compare the effects of market volatilities on Sofwave Medical and Clal Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sofwave Medical with a short position of Clal Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sofwave Medical and Clal Biotechnology.

Diversification Opportunities for Sofwave Medical and Clal Biotechnology

-0.2
  Correlation Coefficient

Good diversification

The 3 months correlation between Sofwave and Clal is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Sofwave Medical and Clal Biotechnology Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Clal Biotechnology and Sofwave Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sofwave Medical are associated (or correlated) with Clal Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Clal Biotechnology has no effect on the direction of Sofwave Medical i.e., Sofwave Medical and Clal Biotechnology go up and down completely randomly.

Pair Corralation between Sofwave Medical and Clal Biotechnology

Assuming the 90 days trading horizon Sofwave Medical is expected to under-perform the Clal Biotechnology. In addition to that, Sofwave Medical is 1.76 times more volatile than Clal Biotechnology Industries. It trades about -0.14 of its total potential returns per unit of risk. Clal Biotechnology Industries is currently generating about -0.13 per unit of volatility. If you would invest  3,880  in Clal Biotechnology Industries on August 31, 2024 and sell it today you would lose (200.00) from holding Clal Biotechnology Industries or give up 5.15% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Sofwave Medical  vs.  Clal Biotechnology Industries

 Performance 
       Timeline  
Sofwave Medical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sofwave Medical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Sofwave Medical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Clal Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Clal Biotechnology Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Sofwave Medical and Clal Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sofwave Medical and Clal Biotechnology

The main advantage of trading using opposite Sofwave Medical and Clal Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sofwave Medical position performs unexpectedly, Clal Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Clal Biotechnology will offset losses from the drop in Clal Biotechnology's long position.
The idea behind Sofwave Medical and Clal Biotechnology Industries pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Share Portfolio
Track or share privately all of your investments from the convenience of any device
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
FinTech Suite
Use AI to screen and filter profitable investment opportunities